Results 61 to 70 of about 5,148 (157)

Virological response to adefovir monotherapy and the risk of adefovir resistance

World Journal of Gastroenterology, 2011
To evaluate virological response to adefovir (ADV) monotherapy and emergence of ADV-resistant mutations in lamivudine (LAM)-resistant chronic hepatitis B patients.Seventy-seven patients with documented LAM resistance who were treated with 10 mg/d ADV for > 96 wk were analyzed for ADV resistance.At week 48 and 96, eight (10%) and 14 (18%) of 77 LAM ...
Dong Hyun, Sinn, Hyang Ie, Lee, Geum-Youn, Gwak, Moon Seok, Choi, Kwang Cheol, Koh, Seung Woon, Paik, Byung Chul, Yoo, Joon Hyeok, Lee   +7 more
openaire   +2 more sources

Eficácia do adefovir dipivoxil, entecavir e telbivudina para o tratamento da hepatite crônica B: revisão sistemática The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review

Revista da Sociedade Brasileira de Medicina Tropical, 2010
INTRODUÇÃO: A hepatite crônica B é uma das doenças infecciosas mais frequentes no mundo e constitui um grave problema de saúde pública MÉTODOS: Para avaliar a eficácia dos análogos de núcleosídeo/nucletídeo utilizados no seu tratamento (adefovir ...
Alessandra Maciel Almeida, Andréia Queiroz Ribeiro, Cristiane Aparecida Menezes de Pádua, Cristina Mariano Ruas Brandão, Eli Iôla Gurgel Andrade, Mariângela Leal Cherchiglia, Ricardo Andrade Carmo, Francisco de Assis Acurcio   +7 more
doaj   +1 more source

Spectrophotometric Determination of Adefovir Dipivoxil in bulk and Pharmaceutical Formulation

E-Journal of Chemistry, 2008
Two selective and sensitive spectrophotometric methods have been developed for the estimation of adefovir dipivoxil in bulk and pharmaceutical preparations.
Zaheer Ahmed, Y. N. Manohara, K. P. Channabasawaraj, Manish Majumdar   +3 more
doaj   +1 more source

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran

Iranian Journal of Microbiology, 2013
Background Objectives: The risk of adefovir dipivoxil resistance emergence has increased in lamivudine-resistant hepatitis B infected patients. The mutations known as causing adefovir resistance, rtN236T and rtA181V/T, are detected within the D and B ...
Seyed Hamidreza Monavari, Hossein Keyvani, Hamidreza Mollaie, Rouhollah Vahabpour Roudsari   +3 more
doaj  

Adefovir [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

The treatment of chronic hepatitis B: Focus on adefovir-like antivirals

Therapeutics and Clinical Risk Management, 2008
Hans Ludger TillmannMedizinische Klinik und Poliklinik II, Universität Leipzig, GermanyAbstract: Several options for the treatment of hepatitis B have been licensed in the last years: interferon, pegylated interferon, lamivudine, adefovir ...
Hans Ludger Tillmann
doaj  

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B

Drug Design, Development and Therapy, 2013
Daniel C Chao, Ke-Qin HuDivision of Gastroenterology and Hepatology, University of California, Irvine Medical Center, Orange, CA, USAAbstract: Chronic hepatitis B continues to be a global problem, with an estimated 240 million cases according to the
Chao DC, Hu KQ
doaj  

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

ClinicoEconomics and Outcomes Research, 2012
Naoky Tsai,1 Lennox Jeffers,2 Lael Cragin,3 Sonja Sorensen,3 Wenqing Su,3 Lisa Rosenblatt,4 Hong Tang,4 Tony Hebden,4 Timothy Juday41John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA; 2University of Miami School of Medicine, Miami,
Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T   +8 more
doaj  

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

ClinicoEconomics and Outcomes Research, 2011
Giorgio L Colombo1,2, Giovanni B Gaeta3, Mauro Viganò4, Sergio Di Matteo21University of Pavia, School of Pharmacy, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy; 3Viral Hepatitis Unit, Second University, Naples, Italy ...
Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al   +3 more
doaj  

Treatment of Chronic Hepatitis B

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2007
Background and objectives:The primary goal of therapy in patients with chronic hepatitis B is durable suppression of HBV DNA to the lowest possible level.
GH Montazeri, MR Ghadir, M Rohban, A Estakhri   +3 more
doaj